HIV and AIDS Trial, Recruiting (NCT07030075)

HIV and AIDS Trial, Recruiting NCT07030075 Sponsor: Centre for Infectious Disease Research in Zambia Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT07030075 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older
People who are currently experiencing flu-like symptoms or an acute respiratory infection, including at least 2 of the following for between 2 and 7 days: cough, sore throat, fever, sneezing, congestion, muscle aches, fatigue, wheezing, or shortness of breath
People who are willing to share their HIV status or be tested for HIV as part of the trial
People who are willing to share their COVID-19 vaccination history
People who are able and willing to give their informed consent to take part
People who are willing to provide a nasal or nasopharyngeal (back of the nose/throat) sample as part of standard care
People who are willing to wear a mask and provide a breath sample for the study
People who are willing to fill in a daily symptom diary for 7 days
People who are willing to attend follow-up study visits for up to two weeks after joining the trial

Who may not be able to join:

People who are unwilling to provide reference standard samples, such as nasopharyngeal (nose/throat) swabs
People whose symptoms have been present for more than 7 days
People who are unwilling or unable to give informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07030075

Sponsor: Centre for Infectious Disease Research in Zambia

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

More information: https://clinicaltrials.gov/study/NCT07030075

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older
People who are currently experiencing flu-like symptoms or an acute respiratory infection, including at least 2 of the following for between 2 and 7 days: cough, sore throat, fever, sneezing, congestion, muscle aches, fatigue, wheezing, or shortness of breath
People who are willing to share their HIV status or be tested for HIV as part of the trial
People who are willing to share their COVID-19 vaccination history
People who are able and willing to give their informed consent to take part
People who are willing to provide a nasal or nasopharyngeal (back of the nose/throat) sample as part of standard care
People who are willing to wear a mask and provide a breath sample for the study
People who are willing to fill in a daily symptom diary for 7 days
People who are willing to attend follow-up study visits for up to two weeks after joining the trial

Who may not be able to join:

People who are unwilling to provide reference standard samples, such as nasopharyngeal (nose/throat) swabs
People whose symptoms have been present for more than 7 days
People who are unwilling or unable to give informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre for Infectious Disease Research in Zambia

Registry

ClinicalTrials.gov

Start date

20 May 2025

Est. completion

1 November 2026

Where this trial is recruiting

Zambia

Primary endpoints

Prevalence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov